Joseph E. Cobb Jr., CPIP, has been appointed director of pharmaceutical development at Metrics, Inc. Mr. Cobb will manage all aspects of projects that involve early-phase solid oral dosage development. He also will oversee the company’s potent and cytotoxic drug development services, which include a dedicated and segregated potent facility.
Mr. Cobb has more than 20 years of industry experience, and holds the Certified Pharmaceutical Industry Professional credential from ISPE. He joined the company in 2002.
“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics’ formulation development capabilities,” said Phil Hodges, president of Metrics. “With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”